slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 41,461-41,490
Pages 2,019
Rows per page 30
Component
41,461-41,490 of 60,568
08
The slide uses a horizontal bar chart integrated into a table to represent clinical trial phases.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
21
Includes specific clinical trial safety metrics and footnotes regarding data definitions.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
22
The table displays specific drug administration schedules (mg/kg) for different cycle lengths and days.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
23
Includes abbreviations for indications (LMS, UPS, NSCLC) and trial design details.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
30
The slide uses a table to present clinical trial outcomes (PR/CR) and safety data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
32
The table compares dosing schedules for a clinical trial drug.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
33
BA3021 Ozuriftamab VedotinBioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
35
The slide uses a combination of a summary table for clinical endpoints and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
38
The slide uses a before-after-bridge style comparison between the problem (toxicity) and the solution (BA3182).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
40
The slide uses a two-column layout to represent 1H and 2H of 2023.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
20
Page number 20 visible in bottom right corner.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Financials1 hit
21
The table shows negative cash flow figures for both periods.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Financials1 hit
22
The table presents a standard non-GAAP financial reconciliation.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Financials1 hit
21
Standard financial reconciliation table format.Blue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations 1 hit
22
Blue Apron | Results Presentation Deck | 24 slidesBlue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations 1 hit
23
Blue Apron | Results Presentation Deck | 24 slidesBlue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations 1 hit
04
Uses a comparative structure to contrast Sepsis vs Septic Shock, followed by impact metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The table provides a bottom-up calculation of TAM based on patient volume, test frequency, and pricing, with a projected uplift from the company's product.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
11
The table highlights NPV as the key differentiator. The ROC chart visually confirms IL-6's superior AUC.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The table uses a direct feature-by-feature comparison to establish competitive differentiation.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
Includes a disclaimer about rounding differences.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
12
The slide uses lettered callouts (A-F) to map specific adjustments to their definitions on the right.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations 1 hit
06
Includes a Kaplan-Meier survival curve, an anatomical illustration of tumor locations, and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The chart is a classic 'spider plot' used in oncology clinical trials to visualize individual patient tumor burden changes over time.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide highlights the correlation between RANO response criteria and improved clinical outcomes in H3 K27M-mutant DMG patients.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The table uses a color-coded heatmap to highlight favorable (green) vs unfavorable (pink) characteristics of clinical trial data.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
12
Financial statement data presented in thousands.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
13
Financial data in thousands, except for share and per share amounts.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
17
Note: In thousandsCipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
11
The slide uses a table structure to bridge historical performance with current run-rate and future acquisition pipeline.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank Beat · Financials1 hit